« Return to News | R&D Trends

$100,000 grant aids rapid cancer detection program

Monday, June 24, 2013 03:27 PM

A rapid cancer detection program developed through collaboration between local physicians, the Scottsdale Healthcare Research Institute and Virginia G. Piper Cancer Center at Scottsdale Healthcare has been awarded a $100,000 grant from the Industrial Development Authority (IDA) of Scottsdale.

The Rapid Detection and Assessment of Response (RADAR) program uses radiologic imaging and advanced analysis to assess whether a tumor is responding to treatment. RADAR provides physicians with information to make decisions about a treatment’s effectiveness and whether an alternate treatment is appropriate, according to Ronald Korn, M.D., Ph.D., medical director of Virginia G. Piper Cancer Center.

“Through RADAR we hope to rapidly detect cancers before they become incurable,” said Korn. “Once the cancer is detected and treatment has started, we hope to assess the response rate to the current treatment plan. With this rapid detection, we will make sure patients have the right treatment.”

Korn added that revolutionary methods of advanced imaging and analysis have the potential to detect treatment responses as early as hours after the start of therapy.

“The IDA believes that the RADAR program will have a positive impact on cancer services for our community and ultimately many patients will benefit from this,” said Marc Grayson, president of the IDA board of directors.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.